Share
Trueinvivo exhibited (and attended) the International Conference on Dosimetry and its Applications (ICDA-2) at the University of Surrey from 3rd to 8th July 2016. There was great interest in the micro silica beads and their potential use. The company also made very good international connections and is in the process of signing a Memorandum of Understanding (MOU) with another organisation.
Related Posts
Innovate UK showcases TRUEinvivo® founder for Women in Innovation award, spotlighting Dr. Shakardokht Jafari's success.
TRUEinvivo wins Business Innovation of the Year Award for DOSEmapper™ technology, revolutionizing radiotherapy safety.
TRUEinvivo® is pleased to announce that the patent for the DOSEmapper™ TLD bead strings and Automated DOSEmapper™ TLD Reader was granted in the EU on 6th January 2021
Mount Vernon Cancer Centre pioneers first internal invivo dosimetry with TRUEnvivo® DOSEmapper™, revolutionising radiotherapy precision, patient safety, and treatment accuracy.
